Results 1-11 of 11 for hpv segment:7106827

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

Mr. Tony O'Brien: I will answer that. Later this year there will be a change away from cytology to the HPV test for primary screening. This will have the effect that the cytology capacity required by the programme will fall from approximately 280,000 cases per annum to 50,000 to 70,000 per annum. This is because if the HPV test is negative, the patient or client will simply return to...

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

..., the limitations of that technology internationally. Nowhere else was able to get a better performance or a better or alternative type of test until a new technology called human papillomavirus, HPV, testing recently became available. Ireland will be one of the first countries in the world to introduce HPV testing as part of its cervical screening programme later this year.

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

...it was to be located unless we were directed otherwise. It is a considerable undertaking even to put in place the structures to change the operation of the screening programme and to convert it to HPV testing, that is, looking for the presence of infection with certain types of HPV which are associated with cervical cancer rather than looking down a microscope for the presence of abnormal...

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

Mr. Tony O'Brien: In combination with the HPV vaccine, yes.

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

Mr. Tony O'Brien: I did not say that in my statement. Clearly, it is also the case that the planned move to HPV testing will be an additional enhancement and will replace cytology, which has this known false negative-false positive rate. That is already planned. That is a matter of policy.

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

Colm Burke: Do we have a target date for HPV testing?

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

Mr. John Gleeson: Dr. Holohan might know more about this, but the HPV test being recommended for use is considered to have a higher sensitivity to the disease, meaning that if one gets a negative result, the negative predictive value is better than that achieved through cytology. There is less risk of a false negative or that a person will develop cervical cancer within the next appreciable...

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

...takes place, there is no point in recreating cervical cytology experience, because by the end of this year that test will be obsolete. The screening programme will move to human papillomavirus, HPV, testing, which will deal with many of the vagaries that we have discussed today. Wherever the testing is to take place, there is no merit whatsoever in beginning to create-----

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

...the performance parameters that we are seeing with our programme, we can be confident that we will continue to drive down that mortality. When we supplement that with what we are doing in terms of HPV screening, which will start later year, we can be confident in the screening performance of that. We have substantial reason to continue to express high confidence as leaders in the health...

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

...being worked through and will be confirmed this week. We will hear further detail of this over the course of the afternoon. In addition, in February 2018, the Minister approved the introduction of primary HPV screening for cervical smear samples, and I can confirm that this will be introduced later this year. A Health Information and Quality Authority, HIQA, health technology assessment...

Joint Oireachtas Committee on Health: National Cervical Screening Programme: Department of Health, HSE, CervicalCheck and the National Cancer Control Programme (2 May 2018)

...laboratories mentioned above were appointed under a HSE framework agreement. This framework agreement is still active today and both Quest Diagnostics and Medlab Pathology are still providing cytology and HPV laboratory services, under contract, on behalf of CervicalCheck. I now want to address the findings of the serious incident management team, SIMT, report. I have submitted the full...